87623102

Information

• Trademark
• 87623102

• Source

• Serial Number

  87623102

• Registration Number

  5538932

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  September 26, 2017
  7 years ago

• Registration Date

  August 14, 2018
  6 years ago

• Transaction Date

  February 25, 2025
  4 months ago

• Status Date

  January 31, 2025
  4 months ago

• Published for Opposition Date

  May 29, 2018
  7 years ago

• Location Date

  January 31, 2025
  4 months ago

• Status Code

  705

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  MARSH,BRANDON N

• Attorney Docket Number

  221834-00013

  Attorney Name

  Melanie Howard

• Owners

  • Replimune Limited

Case File Statements

• DM0000: The mark consists of a stylized circular design with points surrounding the outer edge of the circle, within which appears the design of a triangle pointed upward.
• GS0051: Biological preparations in the nature of viruses for the treatment of cancer, tumors, [ infectious, ] oncological [ , autoimmune, and immune system ] diseases and disorders; biological preparations in the nature of viruses for the treatment of cancer; biological preparations in the nature of viruses for inducing immune response; pharmaceuticals, namely, pharmaceutical preparations and pharmaceutical substances for the treatment of cancer, tumors, [ infectious, ] oncological [ , autoimmune, and immune system ] diseases and disorders; [ pharmaceuticals, namely, anti-infectives for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; ] pharmaceuticals for the treatment of cancer; pharmaceuticals preparations for inducing immune response; vaccines; immunotherapy products, namely, pharmaceutical products for the prevention and treatment of cancer, tumors, [ infectious, ] oncological [ , autoimmune, and immune system ] diseases and disorders [ ; gene therapy products, namely, therapeutics for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders ]
• CC0000: Color is not claimed as a feature of the mark.
• GS0421: [ Pharmaceutical drug research and development services; research and development of vaccines and medicines; information, advisory and consultancy services relating to the aforesaid ]

Case File Event Statements

• 1/3/2018 - 7 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 1/3/2018 - 7 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 1/3/2018 - 7 years ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 9/29/2017 - 7 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 9/30/2017 - 7 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 10/3/2017 - 7 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 1/3/2018 - 7 years ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 5/29/2018 - 7 years ago

  14 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/29/2018 - 7 years ago

  15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 4/5/2018 - 7 years ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 4/16/2018 - 7 years ago

  9 - ASSIGNED TO LIE Type: ALIE

• 4/17/2018 - 7 years ago

  10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 4/17/2018 - 7 years ago

  11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 4/22/2018 - 7 years ago

  12 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 5/9/2018 - 7 years ago

  13 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 8/1/2024 - 11 months ago

  19 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 8/1/2024 - 11 months ago

  20 - POST REGISTRATION ACTION MAILED - SEC. 8 & 15 Type: PR23

• 1/29/2025 - 5 months ago

  21 - TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Type: EROP

• 8/14/2018 - 6 years ago

  16 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 8/14/2023 - a year ago

  17 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1

• 1/16/2024 - a year ago

  18 - TEAS SECTION 8 & 15 RECEIVED Type: E815

• 1/30/2025 - 5 months ago

  23 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Type: NA85

• 1/31/2025 - 4 months ago

  24 - REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Type: C15P

• 1/31/2025 - 4 months ago

  25 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Type: NA85

• 1/30/2025 - 5 months ago

  22 - REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Type: C15A